Global Peptide came to us with a vision and zero infrastructure. We built their entire website from the ground up — compliance-ready for Meta and Google before a single product went live.
Global Peptide is an Australian research peptide company supplying high-purity compounds for scientific and laboratory research. Operating in one of the most restrictively advertised eCommerce categories globally — and under Australia’s stringent TGA regulatory environment — their website couldn’t just look good. It had to be completely and verifiably compliant before any paid traffic could flow.
The Problem
Global Peptide had no website, no copy, no structure. They needed everything built — but in a space where Meta and Google both impose strict restrictions on peptide advertising. One wrong word, one non-compliant image, and their entire ad account is at risk before they’ve made a single sale.
Both Meta and Google explicitly restrict peptide advertising. Building for one is hard. Building for both simultaneously — with different policy triggers — required a unified compliance architecture from day one.
With no prior website, there was no starting point. Every product description, category, FAQ, homepage, and blog had to be written from scratch — in research-appropriate language that passes platform review.
A retrofitted compliance fix is always messier than building right the first time. Any lapse at launch — human imagery, outcome language, dosage cues — could trigger account suspension with no revenue buffer to fall back on.
Australia's TGA framework adds a layer of complexity beyond standard global compliance. Product language, disclaimer requirements, and the boundary between research and clinical framing had to align with both platform policies and the local regulatory environment.
Our Approach
We didn't build a website and then check compliance. We built compliance into every decision - from sitemap to sentence.
Before designing the sitemap, we mapped every Meta and Google Ads policy that applies to research peptide brands. We cross-referenced prohibited content categories, trigger words, imagery restrictions, and landing page requirements across both platforms. This became the rulebook every deliverable was written against.
We designed the site's information architecture from scratch — ensuring all product categories used neutral, research-appropriate naming with no outcome, therapeutic, or benefit framing. The navigation, URL structure, and taxonomy were built to pass automated platform crawls as well as human reviewer scrutiny.
We designed and built the complete website with zero human imagery, no lifestyle photography, and no bottle mockups that imply personal use. All product visuals were clean, neutral renders. Every design decision — from hero banners to product page layouts — was made with platform compliance in mind alongside conversion performance.
Every product description, homepage section, FAQ, blog post, and disclaimer was written from scratch in precise, research-oriented language. No benefit claims. No dosage guidance. No outcome framing. All human-use language was replaced with scientifically accurate, research-context copy that converts without triggering platform policy violations.
Before going live, we ran a final compliance sweep against both Meta and Google's current policy documentation. Every landing page, product URL, and ad destination was verified. The site launched with a clean bill of health — ad accounts activated on day one with no policy flags.
Outcomes
Global Peptide launched with a fully compliant, professionally designed research peptide website — and activated both Meta and Google ad accounts on day one. No rebuilds. No suspensions. No compromise.
We came with nothing but a brand name. Ads Digitally built everything — a website we're proud of, copy that works, and the confidence that our ads won't get pulled the moment they go live.
Whether you’re starting from scratch or need a full rebuild — we’ve done it. We know the policies, the pitfalls, and exactly how to build a peptide brand that can actually run ads.
